Don’t miss the latest developments in business and finance.

HUL and GlaxoSmithKline Consumer Healthcare advance on Chandigarh NCLT approval

Image
Capital Market
Last Updated : Feb 27 2020 | 9:50 AM IST

Hindustan Unilever informed that the National Company Law Tribunal (NCLT) Chandigarh has approved a scheme of amalgamation between GlaxoSmithKline Consumer Healthcare and the company.

The FMCG major had announced on 6 November 2019 that the scheme of amalgamation was previously approved by the National Company Law Tribunal, Mumbai Bench vide it's order dated 24 September 2019.

It added that the effective date of the scheme will be communicated upon being finalized by the Transferor Company (GlaxoSmithKline Consumer Healthcare) and the Company (HUL), in accordance with the procedure specified under the Scheme approved by the Mumbai NCL T and Chandigarh NCLT.

Shares of Hindustan Unilever added 0.21% to Rs 2245.60 while those of Glaxosmithkline Consumer Healthcare gained 1.11% to Rs 9745.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Feb 27 2020 | 9:16 AM IST

Next Story